AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32899492 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 11
Study 35014192 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush plus interdental brushes (group TB/IDB)
Number of subjects: 0
Study 35014192 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush plus rubber interdental picks (group TB/RIDB)
Number of subjects: 0
Study 35014192 — intervention group
Group type: COMPARATOR
Intervention: Toothbrush (group TB)
Number of subjects: 0
Study 35014192 — intervention group
Group type: COMPARATOR
Intervention: Toothbrush plus dental floss (group TB/F)
Number of subjects: 0
Study 33596623 — intervention group
Group type: COMPARATOR
Intervention: Alcohol Assisted Photorefractive Keratectomy (AAPRK)
Number of subjects: 29
Study 33596623 — intervention group
Group type: EXPERIMENTAL
Intervention: Transepithelial Photorefractive Keratectomy (TPRK)
Number of subjects: 29
Study 35317615 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor + Aspirin
Number of subjects: 1169
Study 35317615 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor + Placebo
Number of subjects: 1169
Study 32036679 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-based peer support (MPPS) intervention
Number of subjects: 16
Study 35979784 — intervention group
Group type: EXPERIMENTAL
Intervention: TiRobot‐assisted operation (trial group)
Number of subjects: 74
Study 35979784 — intervention group
Group type: COMPARATOR
Intervention: Traditional manual operation (control group)
Number of subjects: 74
Study 32564705 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyurethane peripherally inserted central catheters (n = 17)
Number of subjects: 32
Study 32564705 — intervention group
Group type: COMPARATOR
Intervention: Hydrophobic peripherally inserted central catheters (n = 15)
Number of subjects: 32
Study 32564705 — intervention group
Group type: EXPERIMENTAL
Intervention: Dwell time
Number of subjects: 32
Study 32564705 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic therapy
Number of subjects: 32
Study 32564705 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter design (biomaterial)
Number of subjects: 32
Study 35943328 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting (16 h overnight fasting)
Number of subjects: 50
Study 35943328 — intervention group
Group type: COMPARATOR
Intervention: Re-feeding
Number of subjects: 50
Study 33573861 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted radical prostatectomy (RARP)
Number of subjects: 782
Study 33573861 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic radical prostatectomy (LRP)
Number of subjects: 782
Study 35929135 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC)
Number of subjects: 0
Study 35929135 — intervention group
Group type: COMPARATOR
Intervention: Cytoreductive surgery (CRS) alone
Number of subjects: 0
Study 32706122 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum neurotoxin A (BoNT‐A) injections
Number of subjects: 57
Study 32706122 — intervention group
Group type: COMPARATOR
Intervention: Two‐duct ligation of the submandibular glands
Number of subjects: 57
Study 34089749 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity (HF) simulator (SimBaby™, Laerdal)
Number of subjects: 128
Study 34089749 — intervention group
Group type: COMPARATOR
Intervention: Low-cost (LC) simulator (inert infant manikin with SimBaby™ software)
Number of subjects: 128
Study 33128677 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted PCOS
Number of subjects: 122977
Study 32960827 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glutathione (reduced glutathione) daily for 24 weeks
Number of subjects: 58
Study 32960827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 33886440 — intervention group
Group type: EXPERIMENTAL
Intervention: Restaurant owners identified as lesbians
Number of subjects: 1406
Study 33886440 — intervention group
Group type: EXPERIMENTAL
Intervention: Restaurant owners identified as gay
Number of subjects: 1406
Study 33886440 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in the number of women among the owners
Number of subjects: 1406
Study 34049350 — intervention group
Group type: EXPERIMENTAL
Intervention: Rebound tonometry (RT, ic100)
Number of subjects: 72
Study 34049350 — intervention group
Group type: COMPARATOR
Intervention: Goldmann tonometry
Number of subjects: 72
Study 32022604 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilingual children
Number of subjects: 90
Study 32022604 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilingual children
Number of subjects: 90
Study 32022604 — intervention group
Group type: COMPARATOR
Intervention: Monolingual children
Number of subjects: 90
Study 35186959 — intervention group
Group type: EXPERIMENTAL
Intervention: α-Lipoic acid (ALA) 1200 mg/d, intravenous infusion once daily plus standard care
Number of subjects: 17
Study 35186959 — intervention group
Group type: COMPARATOR
Intervention: Standard care plus equal volume saline infusion (placebo)
Number of subjects: 17
Study 35107113 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g day-1 of GP seasoning
Number of subjects: 29
Study 35107113 — intervention group
Group type: COMPARATOR
Intervention: Control (no seasoning consumed)
Number of subjects: 29
Study 34461664 — intervention group
Group type: EXPERIMENTAL
Intervention: G_Game (supervised pelvic floor muscle training through gametherapy)
Number of subjects: 20
Study 34461664 — intervention group
Group type: COMPARATOR
Intervention: G_Control (unsupervised pelvic floor muscle training)
Number of subjects: 20
Study 34461664 — intervention group
Group type: EXPERIMENTAL
Intervention: G_Game
Number of subjects: 20
Study 35179770 — intervention group
Group type: EXPERIMENTAL
Intervention: Persian barley water (PBW) 250 ml daily for two weeks
Number of subjects: 100
Study 34167596 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet breakfast (cereal with sucralose)
Number of subjects: 54
Study 34167596 — intervention group
Group type: COMPARATOR
Intervention: Non-sweet breakfast (plain cereal)
Number of subjects: 54
Study 34167596 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (regardless of exposure)
Number of subjects: 54
Study 34816454 — intervention group
Group type: EXPERIMENTAL
Intervention: Edaravone
Number of subjects: 0
Study 34334656 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (chemo ± radiation)
Number of subjects: 130
Study 34334656 — intervention group
Group type: COMPARATOR
Intervention: Surgery only (control group)
Number of subjects: 130
Study 33880943 — intervention group
Group type: EXPERIMENTAL
Intervention: Habit reversal training (HRT)
Number of subjects: 113
Study 33880943 — intervention group
Group type: EXPERIMENTAL
Intervention: Decoupling (DC)
Number of subjects: 113
Study 33880943 — intervention group
Group type: EXPERIMENTAL
Intervention: Decoupling in sensu (DC-is)
Number of subjects: 113
Study 32902313 — intervention group
Group type: EXPERIMENTAL
Intervention: FamTechCare video support
Number of subjects: 0
Study 32902313 — intervention group
Group type: COMPARATOR
Intervention: Attention control telephone support
Number of subjects: 0
Study 32902313 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert feedback from FamTechCare intervention
Number of subjects: 0
Study 36376952 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D personalized insoles in addition to traditional rehabilitation (bracing and exercises)
Number of subjects: 36
Study 36376952 — intervention group
Group type: COMPARATOR
Intervention: Traditional rehabilitation (bracing and exercises)
Number of subjects: 36
Study 34904467 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg daily for 8 weeks
Number of subjects: 80
Study 34904467 — intervention group
Group type: COMPARATOR
Intervention: Placebo daily for 8 weeks
Number of subjects: 80
Study 35321653 — intervention group
Group type: EXPERIMENTAL
Intervention: Stryker insufflator (STR) group
Number of subjects: 200
Study 35321653 — intervention group
Group type: COMPARATOR
Intervention: Storz insufflator (STO) group
Number of subjects: 200
Study 34464524 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy for Preventing Suicide Behavior (MBCT-S)
Number of subjects: 140
Study 34464524 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment-as-usual (eTAU)
Number of subjects: 140
Study 34430347 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (75 mg/m2) + pemetrexed (500 mg/m2) + bevacizumab (15 mg/kg) (CisPemBev)
Number of subjects: 199
Study 34430347 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin (AUC 6 mg/mL/min) + paclitaxel (200 mg/m2) + bevacizumab (15 mg/kg) (CarPacBev)
Number of subjects: 199
Study 34430347 — intervention group
Group type: EXPERIMENTAL
Intervention: CisPemBev
Number of subjects: 199
Study 34430347 — intervention group
Group type: COMPARATOR
Intervention: CarPacBev
Number of subjects: 199
Study 34964239 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct resin composite post and core (CP)
Number of subjects: 48
Study 34964239 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple fiber posts and resin composite core (FP)
Number of subjects: 48
Study 34964239 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM anatomical post and core (AP)
Number of subjects: 48
Study 34964239 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal cast post and core (MP)
Number of subjects: 48
Study 34183558 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral orbital wall decompression
Number of subjects: 0
Study 34183558 — intervention group
Group type: COMPARATOR
Intervention: Single-wall procedure
Number of subjects: 0
Study 34183558 — intervention group
Group type: COMPARATOR
Intervention: Lateral wall decompression alone
Number of subjects: 0
Study 33031713 — intervention group
Group type: EXPERIMENTAL
Intervention: CMR-guided fibrosis ablation plus pulmonary vein isolation (PVI)
Number of subjects: 155
Study 33031713 — intervention group
Group type: COMPARATOR
Intervention: Pulmonary vein isolation (PVI) alone
Number of subjects: 155
Study 33031713 — intervention group
Group type: EXPERIMENTAL
Intervention: CMR-guided fibrosis ablation plus PVI
Number of subjects: 155
Study 35975917 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-Release Naltrexone (XR-NTX)
Number of subjects: 428
Study 35975917 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine (BUP-NX)
Number of subjects: 428
Study 35975917 — intervention group
Group type: EXPERIMENTAL
Intervention: OUD pharmacotherapy
Number of subjects: 428
Study 35975917 — intervention group
Group type: EXPERIMENTAL
Intervention: Study medication
Number of subjects: 428
Study 35975917 — intervention group
Group type: EXPERIMENTAL
Intervention: Study medication duration
Number of subjects: 428
Study 35975917 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinent weeks
Number of subjects: 428
Study 35975917 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to relapse
Number of subjects: 428
Study 35975917 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanic ethnicity
Number of subjects: 428
Study 35975917 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamilton Depression Rating (HAM-D) score
Number of subjects: 428
Study 35975917 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline sedative use
Number of subjects: 428
Study 33964907 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 6 ml Hylan G-F 20 injection
Number of subjects: 440
Study 33964907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440
Study 35804407 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centred care (PCC) implementation
Number of subjects: 66
Study 32326980 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based digital cognitive behavioural therapy (CBT) intervention
Number of subjects: 242
Study 32326980 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 242
Study 34996968 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT)
Number of subjects: 30
Study 34996968 — intervention group
Group type: COMPARATOR
Intervention: Conventional dressing (non-NPWT)
Number of subjects: 30
Study 33435733 — intervention group
Group type: EXPERIMENTAL
Intervention: ProCore needle (22-gauge)
Number of subjects: 100
Study 33435733 — intervention group
Group type: COMPARATOR
Intervention: Standard needle (22-gauge)
Number of subjects: 100
Study 36243034 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (LBI)
Number of subjects: 30
Study 36243034 — intervention group
Group type: COMPARATOR
Intervention: Standard bupivacaine (0.50% with 1:200,000 epinephrine)
Number of subjects: 30
Study 32968968 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (n = 60) - returned to simulation lab at 3 and 6 months
Number of subjects: 118
Study 32968968 — intervention group
Group type: COMPARATOR
Intervention: Group B (n = 58) - returned to simulation lab only at 6 months
Number of subjects: 118
Study 32968968 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (n = 60) - retested at 3 months
Number of subjects: 118
Study 32826624 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscular tissue oxygen saturation-guided care
Number of subjects: 800
Study 32826624 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure management with nicardipine
Number of subjects: 800
Study 35266971 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who screened positive for depression
Number of subjects: 535
Study 35266971 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower MCS score (worse depression)
Number of subjects: 535
Study 35266971 — intervention group
Group type: COMPARATOR
Intervention: Inflammatory markers (cytokines in tears and HLA‐DR expression by conjunctival surface cells)
Number of subjects: 535
Study 34560012 — intervention group
Group type: EXPERIMENTAL
Intervention: All-trans retinoic acid (10 mg orally twice daily for 12 weeks) plus high-dose dexamethasone (40 mg/day intravenously for 4 consecutive days)
Number of subjects: 132
Study 34560012 — intervention group
Group type: COMPARATOR
Intervention: High-dose dexamethasone alone (40 mg/day intravenously for 4 consecutive days)
Number of subjects: 132
Study 35713247 — intervention group
Group type: EXPERIMENTAL
Intervention: PDRN treatment (two consecutive injections of PDRN one and two days after surgery)
Number of subjects: 44
Study 35713247 — intervention group
Group type: EXPERIMENTAL
Intervention: PDRN treatment
Number of subjects: 44
Study 32989176 — intervention group
Group type: EXPERIMENTAL
Intervention: beta-lactolin
Number of subjects: 50
Study 32989176 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50
Study 36069668 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (1.5 mA, 15 min, bilateral left anodal/right cathodal DLPFC, 2 sessions per week)
Number of subjects: 32
Study 36069668 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 32
Study 34807494 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ketamine (0.5 mg/kg bolus followed by 0.25 mg·kg−1·h−1 infusion)
Number of subjects: 100
Study 34807494 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (equivalent dose and regimen to ketamine)
Number of subjects: 100
Study 34807494 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ketamine
Number of subjects: 100
Study 34807494 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 100
Study 33487035 — intervention group
Group type: COMPARATOR
Intervention: High dose vitamin D supplementation
Number of subjects: 0
Study 33487035 — intervention group
Group type: COMPARATOR
Intervention: Zinc supplementation
Number of subjects: 0
Study 32751788 — intervention group
Group type: EXPERIMENTAL
Intervention: XL-CAS
Number of subjects: 15
Study 32751788 — intervention group
Group type: EXPERIMENTAL
Intervention: Mi-CAS
Number of subjects: 15
Study 32751788 — intervention group
Group type: COMPARATOR
Intervention: Ca-CAS
Number of subjects: 15
Study 36056331 — intervention group
Group type: EXPERIMENTAL
Intervention: Introductory ultrasound course
Number of subjects: 20
Study 36056331 — intervention group
Group type: COMPARATOR
Intervention: No additional education (control group)
Number of subjects: 20
Study 32676136 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulpotomy with mineral trioxide aggregate (PMTA)
Number of subjects: 550
Study 32676136 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulpotomy with calcium-enriched mixture (PCEM)
Number of subjects: 550
Study 32676136 — intervention group
Group type: COMPARATOR
Intervention: Root canal therapy (RCT)
Number of subjects: 550
Study 32676136 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments (PMTA, PCEM, RCT)
Number of subjects: 550
Study 32676136 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative pain factors
Number of subjects: 550
Study 35523749 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine combined with dexmedetomidine (group RD)
Number of subjects: 160
Study 35523749 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine combined with sufentanil (group RS)
Number of subjects: 160
Study 33297825 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor nutritional outcomes (cases)
Number of subjects: 678
Study 33297825 — intervention group
Group type: COMPARATOR
Intervention: Qualitative data
Number of subjects: 678
Study 36295619 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser micro-grooved (LMG) platform switched implants and abutments (I&A)
Number of subjects: 16
Study 36295619 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-diabetic)
Number of subjects: 16
Study 33639440 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task intervention
Number of subjects: 76
Study 33639440 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory recall without a dual-task (‘recall only’)
Number of subjects: 76
Study 33639440 — intervention group
Group type: COMPARATOR
Intervention: No task (control group)
Number of subjects: 76
Study 32972777 — intervention group
Group type: EXPERIMENTAL
Intervention: TI with transparency
Number of subjects: 30
Study 32972777 — intervention group
Group type: COMPARATOR
Intervention: TI without transparency
Number of subjects: 30
Study 32972777 — intervention group
Group type: COMPARATOR
Intervention: Standard 3D rendering
Number of subjects: 30
Study 35795613 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with floating acupuncture
Number of subjects: 68
Study 35795613 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture (control group)
Number of subjects: 68
Study 33218839 — intervention group
Group type: EXPERIMENTAL
Intervention: B-mode
Number of subjects: 1203
Study 33218839 — intervention group
Group type: EXPERIMENTAL
Intervention: B-mode plus color Doppler
Number of subjects: 1203
Study 32319154 — intervention group
Group type: EXPERIMENTAL
Intervention: Bespoke smoking cessation (BSC) package offered up to 12 individual sessions with a mental health smoking cessation practitioner
Number of subjects: 526
Study 32319154 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 526
Study 34403648 — intervention group
Group type: EXPERIMENTAL
Intervention: MgSO4 (60 mg.kg‐1) with rocuronium 0.3 mg.kg‐1
Number of subjects: 180
Study 34403648 — intervention group
Group type: EXPERIMENTAL
Intervention: MgSO4 (60 mg.kg‐1) with rocuronium 0.6 mg.kg‐1
Number of subjects: 180
Study 34403648 — intervention group
Group type: EXPERIMENTAL
Intervention: MgSO4 (60 mg.kg‐1) with rocuronium 1.2 mg.kg‐1
Number of subjects: 180
Study 34403648 — intervention group
Group type: COMPARATOR
Intervention: Control (saline) with rocuronium 0.3 mg.kg‐1
Number of subjects: 180
Study 34403648 — intervention group
Group type: COMPARATOR
Intervention: Control (saline) with rocuronium 0.6 mg.kg‐1
Number of subjects: 180
Study 34403648 — intervention group
Group type: COMPARATOR
Intervention: Control (saline) with rocuronium 1.2 mg.kg‐1
Number of subjects: 180
Study 32981192 — intervention group
Group type: EXPERIMENTAL
Intervention: Days with clinical hypoglycemia (54-69 mg/dL)
Number of subjects: 122
Study 32981192 — intervention group
Group type: EXPERIMENTAL
Intervention: Days with clinically serious hypoglycemia (<54 mg/dL)
Number of subjects: 122
Study 32981192 — intervention group
Group type: COMPARATOR
Intervention: Days without hypoglycemia
Number of subjects: 122
Study 33749317 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 108
Study 33749317 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 34759049 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aid use for six months
Number of subjects: 32
Study 34759049 — intervention group
Group type: COMPARATOR
Intervention: Waiting control group
Number of subjects: 32
Study 35710444 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline post-exposure prophylaxis (dPEP)
Number of subjects: 446
Study 35710444 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (STI screening and treatment and risk-reduction counseling without dPEP)
Number of subjects: 446
Study 33275326 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone and bupropion (NB)
Number of subjects: 2073
Study 33275326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2073
Study 35156933 — intervention group
Group type: COMPARATOR
Intervention: Misinformation only
Number of subjects: 500
Study 35156933 — intervention group
Group type: EXPERIMENTAL
Intervention: Misinformation + correction
Number of subjects: 500
Study 35156933 — intervention group
Group type: EXPERIMENTAL
Intervention: Misinformation + correction + rebuke
Number of subjects: 500
Study 35156933 — intervention group
Group type: EXPERIMENTAL
Intervention: Misinformation + correction + rebuke + second correction
Number of subjects: 500
Study 35911215 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality serious game training program, twice a day for at least 10 days during hospitalization
Number of subjects: 64
Study 35911215 — intervention group
Group type: COMPARATOR
Intervention: Standard psychiatric care
Number of subjects: 64
Study 35156252 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion intervention
Number of subjects: 30
Study 35156252 — intervention group
Group type: COMPARATOR
Intervention: Body exposure intervention
Number of subjects: 30
Study 33239197 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar Loop
Number of subjects: 40
Study 33239197 — intervention group
Group type: COMPARATOR
Intervention: Bipolar diathermy
Number of subjects: 40
Study 33838565 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral dose of 1 tablet containing 10 mg enalapril and 0.8 mg folic acid
Number of subjects: 783